Skip to main content

Table 5 Adverse events that occurred in more than 1% of the patients

From: Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)

 

Number of patients (%), n = 396

Any adverse event

186 (47.0)

Psychotic symptoms

28 (7.1)

Extrapyramidal symptoms

12 (3.0)

Akathisia

8 (2.0)